BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9449042)

  • 1. The IGF-I receptor and cancer.
    Baserga R; Resnicoff M; Dews M
    Endocrine; 1997 Aug; 7(1):99-102. PubMed ID: 9449042
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the IGF-I receptor in apoptosis.
    Baserga R; Resnicoff M; D'Ambrosio C; Valentinis B
    Vitam Horm; 1997; 53():65-98. PubMed ID: 9197178
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation.
    Pass HI; Mew DJ; Carbone M; Donington JS; Baserga R; Steinberg SM
    Dev Biol Stand; 1998; 94():321-8. PubMed ID: 9776253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin-like growth factor I receptor: a key to tumor growth?
    Baserga R
    Cancer Res; 1995 Jan; 55(2):249-52. PubMed ID: 7812953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
    Rubin R; Baserga R
    Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation.
    Li M; He Z; Ermakova S; Zheng D; Tang F; Cho YY; Zhu F; Ma WY; Sham Y; Rogozin EA; Bode AM; Cao Y; Dong Z
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):598-605. PubMed ID: 17372258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor.
    Steller MA; Zou Z; Schiller JT; Baserga R
    Cancer Res; 1996 Nov; 56(21):5087-91. PubMed ID: 8895768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy.
    Bähr C; Groner B
    Growth Horm IGF Res; 2004 Aug; 14(4):287-95. PubMed ID: 15231297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis.
    Samani AA; Brodt P
    Surg Oncol Clin N Am; 2001 Apr; 10(2):289-312, viii. PubMed ID: 11382588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
    Miura M; Li S; Baserga R
    Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation.
    Lecosnier S; Cordier C; Simon P; François JC; Saison-Behmoaras TE
    FASEB J; 2011 Jul; 25(7):2201-10. PubMed ID: 21402719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles in cells transformed by overexpression of the IGF-I receptor.
    Loughran G; Huigsloot M; Kiely PA; Smith LM; Floyd S; Ayllon V; O'Connor R
    Oncogene; 2005 Sep; 24(40):6185-93. PubMed ID: 15940254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
    Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
    Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
    Werner H; Maor S
    Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of nuclear phospholipase C signaling through type 1 IGF receptor.
    Cocco L; Capitani S; Maraldi NM; Martelli AM; Mazzotti G; Manzoli FA
    J Endocrinol Invest; 2004; 27(6 Suppl):143-5. PubMed ID: 15481815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 and BRCA1 signalling pathways in familial cancer.
    Werner H; Bruchim I
    Lancet Oncol; 2012 Dec; 13(12):e537-44. PubMed ID: 23182194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number.
    Rubini M; Hongo A; D'Ambrosio C; Baserga R
    Exp Cell Res; 1997 Feb; 230(2):284-92. PubMed ID: 9024787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the IGF axis in hepatocarcinogenesis.
    Scharf JG; Braulke T
    Horm Metab Res; 2003; 35(11-12):685-93. PubMed ID: 14710347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.